BridgeBio Pharma Inc
BBIO
Market Cap$5.38B
Close$
$-9.00
130% downside
Current Fair Value
130% downsideOvervalued by 130% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.38 Billion |
|---|---|
| Enterprise Value | $6.57 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-3.18 |
| Beta | 2.09 |
| Outstanding Shares | 187,129,260 |
| Avg 30 Day Volume | 1,512,794 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -9.99 |
|---|---|
| PEG | 13.34 |
| Price to Sales | 29.97 |
| Price to Book Ratio | -5.0 |
| Enterprise Value to Revenue | 30.07 |
| Enterprise Value to EBIT | -13.9 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0.26 |
| Debt to Equity | -1.63 |
Revenue Sources
No data
ESG Score
No data
About BridgeBio Pharma Inc
CEO: Neil Kumar